These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 875393)

  • 1. Effects of subcutaneously implanted sustained-release cyclophosphamide capsules on Walker 256 solid rat tumor.
    Fu JC; Moyer DL; Cuevas J; Young R; Elshire D
    J Surg Oncol; 1977; 9(3):235-41. PubMed ID: 875393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of intramuscular Walker 256 rat tumor to sustained-release cyclophosphamide and ARA-C capsules.
    Fu JC; Moyer DL; Cuevas J; Cummings L; Eaton A; Elshire D
    J Surg Oncol; 1978; 10(2):133-40. PubMed ID: 642513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained delivery of 3H-thymidine by means of ceramic capsules in rats.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1989; 25():169-77. PubMed ID: 2742964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclophosphamide and mitomycin C on Walker carcinosarcoma 256 grown in liver and muscle.
    Mathur IS; Singh NB; Gupta HP; Gupta SK
    Indian J Med Res; 1979 Feb; 69():284-9. PubMed ID: 429035
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocompatibility of steroid-HA delivery system using adult castrated rams as a model.
    Benghuzzi H; England B
    Biomed Sci Instrum; 2001; 37():275-80. PubMed ID: 11347402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding.
    Donelli MG; Guaitani A; Torti L; Damia G; Corti F; Bianchi M; Tortoreto M; Pantarotto C; Bartosek I
    Oncology; 1986; 43(4):257-63. PubMed ID: 3725287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental evaluation of tumor therapy with cytostatic agents deposited in the abdominal cavity in acetylcellulose].
    Chissov VI; Borisov VI; Rusakov IG; Shchitkov KG; Il'ina AI
    Eksp Onkol; 1987; 9(1):65-8. PubMed ID: 3816661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
    Schmid FA; Otter GM; Stock CC
    Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of locally implanted complexes of adriamycin-hydroxyapatite complexes on tumor--study of a new alternative treatment for hepatic cancer.
    Xia Q; Nie H; Chen D; Chen J; Tian Y; Zhang J
    J Tongji Med Univ; 1999; 19(3):219-22. PubMed ID: 12840899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
    Teichmann B
    Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
    [No Abstract]   [Full Text] [Related]  

  • 13. Extended immunosuppression with cyclophosphamide using controlled-release polymeric implants.
    Ormrod DJ; Cawley S; Miller TE
    Int J Immunopharmacol; 1985; 7(4):443-8. PubMed ID: 4044088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor (VEGF-A) in rat mandibular salivary gland during paraneoplastic process and treatment with cyclophosphamide and melatonin.
    Ovsyanko EV; Kulishenko AO; Lushnikova EL; Vinogradov AS; Zhurakovskii IP; Pustovetova MG; Ovsyanko YU
    Bull Exp Biol Med; 2015 Mar; 158(5):676-80. PubMed ID: 25778658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of blood-CSF barrier by tumor invasion into the meninges.
    Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
    J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumor activity of CPT-11 against rat Walker 256 carcinoma].
    Furuta T; Yokokura T; Mutai M
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2757-60. PubMed ID: 3415271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.